High intake of the artificial sweetener sucralose may reduce the efficacy of ICIs in patients with cancer, data suggest.

Prevalence of glycemic control and use of diabetes technology lowest in Hispanic, non-Hispanic Black, Medicaid-insured.

Stereotactic ablative body radiation therapy (SABR) is actively being explored for patients with renal cell carcinoma (RCC).

The poll also found a record 53% of adults consider moderate drinking — one or two drinks a day — is bad for their health. That’s up sharply from 28% in 2015, 39% in 2023, and 45% one year ago.

Improved maximum urinary flow rate and lower International Prostate Symptom Scores seen for adherent versus nonadherent patients.

DASH, DII are significantly associated with CKD risk, while only DII is associated with CKD severity progression.

There is decreased risk for MACE and all-cause mortality in dialysis-dependent patients with ASCVD who are treated with statins.

(HealthDay News) — In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August data brief published by the ...

(HealthDay News) — Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients with overweight or obesity, according to a study ...

The U.S. Centers for Disease Control and Prevention (CDC) reported that wastewater activity for COVID-19 has climbed to a “moderate” level nationwide, up from “low” the week before.

Age and hematologic disease length are positive predictors for CKD; acute lymphoblastic leukemia is a negative predictive factor.

The FDA has approved an expanded indication of the IV formulation of Avtozma to include the treatment of CRS in patients 2 years of age and older.